- Home
- SLNO vs PTY Comparison
SLNO vs PTY Comparison
Compare SLNO & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLNO | PTY |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2014 | 2002 |
Fundamental Metrics
Financial Performance| Metric | SLNO | PTY |
|---|---|---|
| Price | $34.16 | $12.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $108.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 1.3M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.90 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,450,788.00 | N/A |
| Revenue This Year | $155.44 | N/A |
| Revenue Next Year | $57.99 | N/A |
| P/E Ratio | $94.31 | ★ N/A |
| Revenue Growth | ★ 138.82 | N/A |
| 52 Week Low | $32.63 | $11.70 |
| 52 Week High | $89.12 | $14.69 |
Technical Indicators
Market Signals| Indicator | SLNO | PTY |
|---|---|---|
| Relative Strength Index (RSI) | 32.76 | 17.89 |
| Support Level | $32.63 | N/A |
| Resistance Level | $44.60 | $13.21 |
| Average True Range (ATR) | 2.45 | 0.15 |
| MACD | -0.18 | -0.07 |
| Stochastic Oscillator | 14.19 | 0.52 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About PTY Pimco Corporate & Income Opportunity Fund
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.